Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 3.37 USD 3.69% Market Closed
Market Cap: 426.8m USD

Intrinsic Value

The intrinsic value of one CTKB stock under the Base Case scenario is 4.81 USD. Compared to the current market price of 3.37 USD, Cytek Biosciences Inc is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTKB Intrinsic Value
4.81 USD
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cytek Biosciences Inc

What is Valuation History?
Compare CTKB to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CTKB?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cytek Biosciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cytek Biosciences Inc

Current Assets 380.5m
Cash & Short-Term Investments 265.6m
Receivables 55.2m
Other Current Assets 59.7m
Non-Current Assets 102.1m
PP&E 27.7m
Intangibles 36.1m
Other Non-Current Assets 38.3m
Efficiency

Free Cash Flow Analysis
Cytek Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cytek Biosciences Inc

Revenue
197.1m USD
Cost of Revenue
-88.8m USD
Gross Profit
108.3m USD
Operating Expenses
-133m USD
Operating Income
-24.8m USD
Other Expenses
13.5m USD
Net Income
-11.3m USD
Fundamental Scores

CTKB Profitability Score
Profitability Due Diligence

Cytek Biosciences Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Net Margin
Declining Gross Margin
31/100
Profitability
Score

Cytek Biosciences Inc's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

CTKB Solvency Score
Solvency Due Diligence

Cytek Biosciences Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
80/100
Solvency
Score

Cytek Biosciences Inc's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTKB Price Targets Summary
Cytek Biosciences Inc

Wall Street analysts forecast CTKB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTKB is 5.87 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

Lowest
Price Target
4.04 USD
20% Upside
Average
Price Target
5.87 USD
74% Upside
Highest
Price Target
8.4 USD
149% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cytek Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CTKB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CTKB Insider Trading
Buy and sell transactions by insiders

CTKB News

Other Videos
What is the Intrinsic Value of one CTKB stock?

The intrinsic value of one CTKB stock under the Base Case scenario is 4.81 USD.

Is CTKB stock undervalued or overvalued?

Compared to the current market price of 3.37 USD, Cytek Biosciences Inc is Undervalued by 30%.

Back to Top